716 results on '"Manthey, Jakob"'
Search Results
152. Mid and long-term effects of a SBIRT program for at-risk drinkers attending to an emergency department. Follow-up results from a randomized controlled trial.
153. Abstinence Among Alcohol Use Disorder Patients During the COVID‐19 Pandemic: Insights From Spain
154. Guidelines and reality in studies on the economic costs of alcohol use: a systematic review
155. Classifying Alcohol Control Policies with Respect to Expected Changes in Consumption and Alcohol-Attributable Harm: The Example of Lithuania, 2000–2019
156. Impact of Increasing the Minimum Legal Drinking Age from 18 to 20 Years in Lithuania on All-Cause Mortality in Young Adults—An Interrupted Time-Series Analysis.
157. The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.
158. A systematic comparison of the global comparative risk assessments for alcohol
159. A new perspective on European drinking cultures: a model‐based approach to determine variations in drinking practices among 19 European countries
160. Use of Alcohol, Tobacco, Cannabis, and Other Substances During the First Wave of the SARS-CoV-2 Pandemic in Europe: a Survey on 36,000 European Substance Users
161. Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries (preprint)
162. Classifying Alcohol Control Policies with Respect to Expected Changes in Consumption and Alcohol-Attributable Harm: The Example of Lithuania
163. Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries
164. Perceived appropriateness of alcohol screening and brief advice programmes in Colombia, Mexico and Peru and barriers to their implementation in primary health care – a cross-sectional survey
165. Can Alcohol Control Policies Reduce Liver Cirrhosis Mortality? An Interrupted Time Series Analysis in Lithuania
166. Alcohol Screening and Brief Advice Measure
167. Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?
168. Cannabis use in Europe: Current trends and public health concerns
169. Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion
170. Comparing subjective intoxication with risky single-occasion drinking in a European sample
171. Gender Differences and the Role of Social Inequality in Alcohol’s Harm to Others in Europe
172. Diagnostik und Behandlung alkoholbezogener Störungen – Versorgerbefragung zur Erarbeitung von Strategien der Leitlinienimplementierung
173. Reducing the Harmful Use of Alcohol: Have International Targets Been Met?
174. Controlled administration of cannabis to mitigate cannabis-attributable harm among recreational users: a quasi-experimental study in Germany
175. Alkoholkonsum in Deutschland und Europa während der SARS-CoV-2 Pandemie
176. Impact of low and no alcohol beers on purchases of alcohol: interrupted time series analysis of British household shopping data, 2015–2018
177. Future of surveys in the alcohol field
178. Further considerations of the best indicator for the harmful use of alcohol
179. The elusiveness of representativeness in general population surveys for alcohol
180. Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study
181. Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study)
182. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review
183. Why Is Per Capita Consumption Underestimated in Alcohol Surveys? Results from 39 Surveys in 23 European Countries
184. Meeting the Global NCD Target of at Least 10% Relative Reduction in the Harmful Use of Alcohol: Is the WHO European Region on Track?
185. Cannabis and public health: a global experiment without control
186. Alcohol use in times of the COVID 19: Implications for monitoring and policy
187. What is the best indicator of the harmful use of alcohol? A narrative review
188. Study report
189. SPIRIT checklist for F1000 study protocol
190. Additional file 2 of Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review
191. Model consent form
192. Referee report. For: The health, economic, and social effects of cannabis use in Thailand [version 1; peer review: 1 approved with reservations, 1 not approved]
193. Additional file 1 of Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review
194. Mortality from Alcoholic Cardiomyopathy: Exploring the Gap between Estimated and Civil Registry Data
195. Alcohol Use in Germany and Europe during the SARS-CoV-2 Pandemic
196. Why Is Per Capita Consumption Underestimated in Alcohol Surveys? Results from 39 Surveys in 23 European Countries
197. Versorgung von Personen mit riskantem Alkoholkonsum und schwerer Alkoholkonsumstörung in Bremen : bedarfsgerecht und leitlinienkonform?
198. Welchen Beitrag leistet die Wissenschaft in der deutschen Debatte um die Cannabislegalisierung?: How is Science Contributing to the German Debate on the Legalization of Cannabis?
199. Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion.
200. Changes in alcohol consumption in Spain between 1990 and 2019.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.